Archive: February, 2024

GUIDE Program Prepares DOD to Defend Against the Unknown
February 27, 2024
The graphic shows the various elements included in the decision tree for the GUIDE program. The slide is broken in two halves (right and left). The left upper corner shows a microbe, models of manufacturability, efficacy, safety data and pharmacodynamics. On the right side of the slide shows how the GUIDE program will help pair these things for the optimal output through the GUIDE program's capabilities.

Department of Defense Transitions Legacy Special Immunization Program to Commercial Partners
February 16, 2024
Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

CSC2 Moves Full Speed Ahead on the Software Acquisition Pathway
February 6, 2024
A man stands next to a screen displaying maps and explains the results to three men sitting in chairs and listening.


Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.  



JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.